Re-profiling of selected FDA approved drugs against C-jun N-terminal kinase (JNK) in ischemic stroke (Record no. 26679)

MARC details
000 -LEADER
fixed length control field 00949nam a22002057a 4500
040 ## - CATALOGING SOURCE
Transcribing agency Riphah International University
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1
Author Mark ZIK
100 ## - MAIN ENTRY--PERSONAL NAME
Authorship Zikra Zulfiqar (21863)
245 ## - TITLE STATEMENT
Title Re-profiling of selected FDA approved drugs against C-jun N-terminal kinase (JNK) in ischemic stroke
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication Islamabad
Date of publication 2019
Name of publisher (unpublished)
300 ## - PHYSICAL DESCRIPTION
Extent x, 70 p.
Illustrations : ill., Col.
Dimensions ; 30 cm.
Accompanying material +CD
500 ## - GENERAL NOTE
General note A thesis is submitted in partial fulfillment of the requirements for the degree of Master of Philosophy to the Faculty of Pharmaceutical Sciences.
500 ## - GENERAL NOTE
General note Includes bibliographical references
500 ## - GENERAL NOTE
General note Thesis supervisor: Dr. Fawad Ali Shah
500 ## - GENERAL NOTE
General note Co-supervisor: Dr. Alam Zeb
502 ## - DISSERTATION NOTE
Dissertation note Thesis (M.Phil.)--Riphah International University, 2019
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Subject Pharmacology
Keywords Bioinformatics resouces
-- Neurobehavioral testing
-- Antioxidant analysis
-- Brain infarction
-- Drugs
-- RIPS
942 ## - ADDED ENTRY ELEMENTS (KOHA)
item type Thesis
Holdings
Not for loan Home library Current library Source of acquisition Full call number Barcode Copy number Koha item type
  City Campus City Campus Riphah International University 615.1 ZIK 52553 1 Thesis
Copyright © 2026 Riphah International University | System Administrator